Full text
| |
| Author(s): |
Zumira Aparecida Carneiro
Total Authors: 1
|
| Document type: | Doctoral Thesis |
| Press: | Ribeirão Preto. |
| Institution: | Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas de Ribeirão Preto (PCARP/BC) |
| Defense date: | 2014-12-12 |
| Examining board members: |
Victor Marcelo Deflon;
Maria Teresa Junqueira Garcia
|
| Advisor: | Victor Marcelo Deflon |
| Abstract | |
The parasite Trypanosoma cruzi causes Chagas disease, which remains a serious public health concern and continues to victimize thousands of people, primarily in the poorest regions of Latin America. In the search for new therapeutic drugs against T. cruzi, here we have evaluated both the in vitro and the in vivo activity of 5-hydroxy-3-methyl-5-phenyl-pyrazoline-1-(S-benzyldithiocarbazate) (H2bdtc). This compound was characterized by elemental analysis, UV-visible spectroscopy, infrared, NMR and mass spectrometry. Biological experiments were conducted with H2bdtc as a free compound or encapsulated into solid lipid nanoparticles; we compared the results with those achieved by using the currently employed drug, benznidazole. H2bdtc encapsulated into solid lipid nanoparticles (a) effectively reduced parasitemia in mice at concentrations 100 times lower than that normally employed for benznidazole (clinically applied at a concentration of 400 ?mol kg-1 day-1); (b) diminished inflammation and lesions of the liver and heart; and (c) resulted in 100,0% survival of mice infected with T. cruzi. Biological mechanism elucidation of H2bdtc compound was analyzed based on the interaction with DNA and Human Serum Albumin (HSA). Based on the data related to the in vitro and in vivo trypanocidal activity of H2bdtc it was taken as potent trypanocidal agent. Studies developed on this project allow concluding that H2bdtc is a possible new drug to be used against Chagas Disease. (AU) | |
| FAPESP's process: | 10/20610-0 - "Evaluation of trypanocidal activity in vitro and in vivo the compound 5-hydroxy- 3-methyl- pyrazoline - 5-phenyl -1- ( S- benzilditiocarbazato ) in aqueous medium and in the drug delivery system." |
| Grantee: | Zumira Aparecida Carneiro |
| Support Opportunities: | Scholarships in Brazil - Doctorate |